Dependence potential of nicotine replacement treatments: Effects of product type, patient characteristics, and cost to user

Preventive Medicine

Volumn 44, Issue 3, 2007, Pages 230-234

  Hajek, Peter ^a   McRobbie, Hayden ^b   Gillison, Fiona ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c University of Bath   (United Kingdom)

Author keywords

Long term use; Nicotine replacement therapy; Smoking cessation; Tobacco dependence

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NEBULIZATION; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; UNITED KINGDOM;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRANASAL; ADMINISTRATION, SUBLINGUAL; ADULT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; NICOTINE; PROGRAM EVALUATION; SMOKING; SMOKING CESSATION; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 33847335100     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2006.10.005     Document Type: Article

References (30)

1. Blondal T. Controlled trial of nicotine polacrilex gum with supportive measures. Arch. Intern. Med. 149 (1989) 1818-1821
2. Blondal T., Gudmundsson L.J., Olafsdottir I., Gustavsson G., and Westin A. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 318 (1999) 285-288
3. Chesterman J., Judge K., Bauld L., and Ferguson J. How effective are the English smoking treatment services in reaching disadvantaged smokers?. Addiction 100 Suppl. 2 (2005) 36-45
4. Department of Health. The NHS Plan: A Plan for Investment; A Plan for Reform (2000), The Stationary Office, London
5. Department of Health, 2001. NHS Smoking cessation services: service and monitoring guidance. 2001/02. Issued 11 April 2001. In, London.
6. Department of Health, 2005. Statistics on smoking cessation services in England, April 2004 to March 2005. Available at: http://www.dh.gov.uk/assetRoot/04/11/52/94/04115294.pdf. In: Department of Health, England, UK.
7. Eliasson B., Taskinen M.R., and Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 94 (1996) 878-881
8. Greenland S., Satterfield M.H., and Lanes S.F. A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf. 18 (1998) 297-308
9. Hajek P. Withdrawal-oriented therapy for smokers. Br. J. Addict. 84 (1989) 591-598
10. Hajek P. What limits the efficacy of current nicotine replacement treatments?. In: Bock G., and Corrigal W. (Eds). Understanding Nicotine and Tobacco Addiction (2006), Wiley ISBN: 0-470-01657-01654
11. Hajek P., Jackson P., and Belcher M. Long-term use of nicotine chewing gum. Occurrence, determinants, and effect on weight gain. JAMA 260 (1988) 1593-1596
12. Hajek P., West R., Foulds J., Nilsson F., Burrows S., and Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch. Intern. Med. 159 (1999) 2033-2038
13. Hatsukami D., Huber M., Callies A., and Skoog K. Physical dependence on nicotine gum: effect of duration of use. Psychopharmacology (Berlin) 111 (1993) 449-456
14. Heatherton T., Kozlowski L., Frecker R., and Fagerstrom K. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 86 (1991) 1119-1127
15. Hjalmarson A., Franzon M., Westin A., and Wiklund O. Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch. Intern. Med. 154 (1994) 2567-2572
16. Hughes J.R., Gust S.W., Keenan R., Fenwick J.W., Skoog K., and Higgins S.T. Long-term use of nicotine vs placebo gum. Arch. Intern. Med. 151 (1991) 1993-1998
17. McNeill A., Foulds J., and Bates C. Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction 96 (2001) 1757-1768
18. Murray R.P., Bailey W.C., Daniels K., et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 109 (1996) 438-445
19. National Institute for Clinical Excellence. Guidance on the Use of Nicotine Replacement Therapy (NRT) and Bupropion for Smoking Cessation (2002), National Institute for Clinical Excellence, London
20. Nides M.A., Rakos R.F., Gonzales D., et al. Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J. Consult. Clin. Psychol. 63 (1995) 60-69
21. Piasecki T.M., Fiore M.C., and Baker T.B. Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J. Abnorm. Psychol. 107 (1998) 238-251
22. Shiffman S., Hughes J.R., Di Marino M.E., and Sweeney C.T. Patterns of over-the-counter nicotine gum use: persistent use and concurrent smoking. Addiction 98 (2003) 1747-1753
23. Shiffman S., Hughes J.R., Pillitteri J.L., and Burton S.L. Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample. Tob. Control 12 (2003) 310-316
24. Silagy C., Lancaster T., Stead L., Mant D., and Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. (2004) CD000146
25. Sims T.H., and Fiore M.C. Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?. CNS Drugs 16 (2002) 653-662
26. Sutherland G., Stapleton J.A., Russell M.A., et al. Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340 (1992) 324-329
27. USDHHS. Treating Tobacco Use and Dependence (2000), United States Department of Health and Human Services, Agency for Healthcare Research Quality, Rockville, MD
28. West R.J., and Russell M.A. Pre-abstinence smoke intake and smoking motivation as predictors of severity of cigarette withdrawal symptoms. Psychopharmacology (Berlin) 87 (1985) 334-336
29. West R., Hajek P., Foulds J., Nilsson F., May S., and Meadows A. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology (Berlin) 149 (2000) 198-202
30. West R., McNeill A., and Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 55 (2000) 987-999